"Glenmark Pharmaceuticals Europe today has entered into a strategic development & licensing agreement with Celon Pharma SA to develop and market a generic version of GlaxoSmithKline's Seretide Accuhaler product - Fluticasone / Salmeterol dry powder Inhaler in Europe upon commercialisation," the pharma company said in its filing.
first published: Oct 23, 2015 03:11 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty breaks below 26,200 on expiry day, broader markets underperform | Closing Bell
Live: Will Nifty's weakness continue for the second straight day? | Opening Bell
A money superpower you have in your 20s, not in 40s
Live: Nifty snaps 3-day gaining streak, slips below 26,300 on Venezuela tensions | Closing Bell
